Home › Multiple Myeloma › Washington › Tacoma
Pag-aaral pangklinika para sa Multiple Myeloma sa Tacoma, WA
Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tacoma. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1
- Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Nagre-recruitPhase 3
- NorthWest Medical Specialties, PLLC, Tacoma
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Nagre-recruitPhase 4
- Northwest Medical Specialties, PLLC, Tacoma
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Nagre-recruitPhase 1/2
- Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Nagre-recruitPhase 1
- Northwest Medical Specialties, PLLC, Tacoma
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Nagre-recruitPhase 3
- Study Site 103, Tacoma
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Nagre-recruitPhase 3
- Research Site, Puyallup · 8 mi ang layo
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- NorthWest Medical Specialties, PLLC, Tacoma
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Nagre-recruitPhase 1
- American Oncology Network Vista Oncology Division / Physician partner associate, Olympia · 26 mi ang layo
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Northwest Medical Specialties, Tacoma
- Northwest Medical Specialties, Gig Harbor · 8 mi ang layo
- Northwest Medical Specialties, Puyallup · 8 mi ang layo
- at 1 pa
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Nagre-recruitPhase 3
- Research Site, Puyallup · 8 mi ang layo
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Nagre-recruitPhase 3
- Providence Regional Cancer System-Yelm, Yelm · 23 mi ang layo
- Providence Regional Cancer System-Lacey, Lacey · 23 mi ang layo
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Nagre-recruitPhase 3
- GSK Investigational Site, Puyallup · 8 mi ang layo
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY59 pag-aaral
- Boston, MA45 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX39 pag-aaral
- Durham, NC36 pag-aaral
- Nashville, TN31 pag-aaral
- Denver, CO26 pag-aaral
- St. Louis, MO26 pag-aaral
- Rochester, MN25 pag-aaral
- Columbus, OH25 pag-aaral
- Chicago, IL24 pag-aaral
- Milwaukee, WI23 pag-aaral
Iba pang pag-aaral sa Tacoma
- Non-Small Cell Lung Cancer18 pag-aaral
- Kanser sa Suso17 pag-aaral
- Ulcerative Colitis13 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Metastatic Cancer10 pag-aaral
- Crohn's Disease10 pag-aaral
- Colorectal Cancer10 pag-aaral
- Kanser sa Ovary7 pag-aaral
- Melanoma7 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Kanser sa Tiyan6 pag-aaral
- Kanser sa Pancreas6 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.